Hokanson David E, Laakso Joseph M, Lin Tianming, Sept David, Ostap E Michael
The Pennsylvania Muscle Institute and Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085, USA.
Mol Biol Cell. 2006 Nov;17(11):4856-65. doi: 10.1091/mbc.e06-05-0449. Epub 2006 Sep 13.
Myo1c is a member of the myosin superfamily that binds phosphatidylinositol-4,5-bisphosphate (PIP(2)), links the actin cytoskeleton to cellular membranes and plays roles in mechano-signal transduction and membrane trafficking. We located and characterized two distinct membrane binding sites within the regulatory and tail domains of this myosin. By sequence, secondary structure, and ab initio computational analyses, we identified a phosphoinositide binding site in the tail to be a putative pleckstrin homology (PH) domain. Point mutations of residues known to be essential for polyphosphoinositide binding in previously characterized PH domains inhibit myo1c binding to PIP(2) in vitro, disrupt in vivo membrane binding, and disrupt cellular localization. The extended sequence of this binding site is conserved within other myosin-I isoforms, suggesting they contain this putative PH domain. We also characterized a previously identified membrane binding site within the IQ motifs in the regulatory domain. This region is not phosphoinositide specific, but it binds anionic phospholipids in a calcium-dependent manner. However, this site is not essential for in vivo membrane binding.
肌球蛋白1c(Myo1c)是肌球蛋白超家族的成员,它能结合磷脂酰肌醇-4,5-二磷酸(PIP₂),将肌动蛋白细胞骨架与细胞膜相连,并在机械信号转导和膜运输中发挥作用。我们在这种肌球蛋白的调节域和尾部结构域中定位并鉴定了两个不同的膜结合位点。通过序列、二级结构和从头计算分析,我们确定尾部的一个磷酸肌醇结合位点是一个假定的普列克底物蛋白同源(PH)结构域。已知在先前鉴定的PH结构域中对多磷酸肌醇结合至关重要的残基的点突变,在体外抑制Myo1c与PIP₂的结合,破坏体内膜结合,并破坏细胞定位。该结合位点的延伸序列在其他肌球蛋白-I同工型中是保守的,表明它们含有这个假定的PH结构域。我们还对调节域中IQ模体内先前鉴定的一个膜结合位点进行了表征。该区域不是磷酸肌醇特异性的,但它以钙依赖的方式结合阴离子磷脂。然而,这个位点对于体内膜结合不是必需的。